This Article Full Text Full Text (PDF) All Versions of this Article: 0008-5472.CAN-08-4570v1 69/14/5681    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Chang, P.-C. Articles by Kung, H.-J. PubMed PubMed Citation Articles by Chang, P.-C. Articles by Kung, H.-J.

Kruppel-Associated Box Domain-Associated Protein-1 as a Latency Regulator for Kaposi's Sarcoma-Associated Herpesvirus and Its Modulation by the Viral Protein Kinase

¹ Department of Biological Chemistry and Molecular Medicine and University of California-Davis Cancer Center; ² Center for Comparative Medicine and Department of Pathology, University of California-Davis, Davis, California and ³ Department of Clinical and Molecular Pharmacology, City of Hope National Medical Center, Duarte, California

Requests for reprints: Hsing-Jien Kung, Department of Biological Chemistry and Molecular Medicine and University of California-Davis Cancer Center, Res III Room 2400, 4645 2nd Avenue, Sacramento, CA 95817. Phone: 916-734-3111; Fax: 916-734-2589; E-mail: hkung{at}ucdavis.edu.

Kaposi's sarcoma-associated herpesvirus (KSHV) has been linked to the development of Kaposi's sarcoma, a major AIDS-associated malignancy, and to hematologic malignancies, including primary effusion lymphoma and multicentric Castleman's disease. Like other herpesviruses, KSHV is capable of both latent and lytic replication. Understanding the molecular details associated with this transition from latency to lytic replication is key to controlling virus spread and can affect the development of intervention strategies. Here, we report that Kruppel-associated box domain-associated protein-1 (KAP-1)/transcriptional intermediary factor 1β, a cellular transcriptional repressor that controls chromosomal remodeling, participates in the process of switching viral latency to lytic replication. Knockdown of KAP-1 by small interfering RNA leads to KSHV reactivation mediated by K-Rta, a key transcriptional regulator. In cells harboring latent KSHV, KAP-1 was associated with the majority of viral lytic-gene promoters. K-Rta overexpression induced the viral lytic cycle with concomitant reduction of KAP-1 binding to viral promoters. Association of KAP-1 with heterochromatin was modulated by both sumoylation and phoshorylation. During lytic replication of KSHV, KAP-1 was phosphorylated at Ser⁸²⁴. Several lines of evidence directly linked the viral protein kinase to this post-translational modification. Additional studies showed that this phosphorylation of KAP-1 produced a decrease in its sumoylation, consequently decreasing the ability of KAP-1 to condense chromatin on viral promoters. In summary, the cellular transcriptional repressor KAP-1 plays a role in regulating KSHV latency, and viral protein kinase modulates the chromatin remodeling function of this repressor. [Cancer Res 2009;69(14):5681–9]